Navigation Links
Genelabs Technologies to Present at the BIO CEO & Investor Conference
Date:2/7/2008

REDWOOD CITY, Calif., Feb. 7 /PRNewswire-FirstCall/ -- Genelabs Technologies, Inc. (Nasdaq: GNLB) announced today that its Chief Financial Officer Fred Driscoll will present a company update at the BIO CEO Investor Conference at the Waldorf Astoria Hotel Tuesday, February 12, 2008 at 2:00 pm E.T.

The presentation is scheduled to be webcast live and may be accessed by going to the Investor Information section of the Genelabs website at http://www.genelabs.com or through the following URL: http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=GNLB&item_id=17523 37 The presentation will also be available for replay after the presentation for a limited time.

About Genelabs Technologies

Genelabs Technologies, Inc. is a biopharmaceutical company focused on the discovery and development of pharmaceutical products to improve human health. We have built drug discovery capabilities that can support various research and development projects. Genelabs is currently concentrating these capabilities on discovering novel compounds that selectively inhibit replication of the hepatitis C virus and advancing preclinical development of compounds from this hepatitis C virus drug discovery program. We also have late-stage products for hepatitis E virus and lupus. We believe that these high-risk, potentially high reward programs focus our research and development expertise in areas where we have the opportunity to generate either first-in-class or best-in-class products that will address diseases for which current therapies are inadequate. For more information, please visit

SOURCE Genelabs Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Genelabs Technologies, Inc. Announces Resignation of President and CEO
2. Update: Neurobiological Technologies Sets Date for Second Quarter Financial Results and Conference Call
3. Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions
4. Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
5. Guava Technologies Celebrates Tenth Anniversary
6. BioSpecifics Technologies Corp. Announces Repayment of Outstanding Loan
7. Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th
8. Intrasphere Technologies Releases PharmaCM Submissions Management and Authoring Module Powered by Microsoft Office SharePoint Server 2007
9. Neurobiological Technologies Sets Date for Second Quarter Financial Results
10. Emisphere Technologies to Present at BIO CEO & Investor Conference on February 12
11. Vestibular Technologies Is Awarded Contract by Major Group Purchasing Organization (GPO)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009).... 27 Cromoz Inc., located in Resea...bon nanotube-based cancer drug delivery system in ...es, which have functional groups on the walls that...eloped in partnership with the Indian Institute of...ves as a drug delivery vehicle with the ability to...
(Date:11/26/2009)...generation of ultrasmall transistors and more powe...emiconducting nanowires are closer to reality afte...iversity and the University of California at Los A...eate nanowires with layers of different materials ...h is a critical requirement for making efficient t...
(Date:11/25/2009)...r to Speak at Economic Club of Canada , ..., 2009 -- Ambassador to Speak at Economic Club of ...dor for International Investment, and Chairman and...graphy of David Appia go to www.investinfrance.or...meet with press to discuss recent pro-business ini...
(Date:11/25/2009).... 25 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. ( S... announced today that it executed,a joint venture ...ne,Technology Co., Ltd. (Sinovac Dalian). The JV w...uman-use vaccines. Sinovac will contribute its exp...izing world-class vaccines; the,other party will b...
Breaking Biology Technology:North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3French Ambassador for International Investment to Visit Toronto December 11 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3
...e next installment covering the enforcement tactic...week. , , You or your company may have no paten...cerned with patent matters. However, there is a gr...tents to be a main or significant source of revenu... to be concerned with patent matters. , ,In the pa...
...ital Forum has issued an open call for companies ...re venture capitalists, corporate and private inve...thering April 5-6. , ,Dec. 16 is the early applica...n deadline to be considered for participation in t...nal headquarters in St. Louis. , ,Selection of pre...
...z about how gaming is going to transform corporate...em Advanced Distributed Learning Co-Lab are doin...knowledge, learning and industry. , ,Guess what? ... reroute the focus of innovation and development f... great time of year to get a feel for the scope an...
Other Biology Technology:Patent enforcement: What you don't know might hurt you 2Patent enforcement: What you don't know might hurt you 3Patent enforcement: What you don't know might hurt you 4Just in time for Christmas: Retail IT. 2Just in time for Christmas: Retail IT. 3
(Date:11/30/2009)...l of Experimental Biology are pleased to announce...Recherche Scientifique (CNRS) in the Universit de ... JEB Outstanding Paper Prize. ,The prize is awar...nd is intended to encourage young scientists, say...dds that ,we truly appreciate when authors submit ...
(Date:11/30/2009)...rly bird registration rates and register online no...t http://www.iofwco-ecceo10.org/ , WHAT: IOF ...al Osteoporosis Foundation (IOF) and the European ...porosis and Osteoarthritis (ESCEO). More than 5,00...to attend. The exciting scientific programme inclu...
(Date:11/30/2009)...Lithuania, Nov. 30 Neurotechnology... high-precision biometric identification technolog...s core product line: VeriLook 4.0 Software Devel...atcher 3.1 SDK for large-scale multi-biometric an...IS). Expanded capabilities in VeriLook 4.0 provide...
Breaking Biology News(10 mins):French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 3H1N1 Focus of California Hospital Association Disaster Planning Conference 57101 1H1N1 Focus of California Hospital Association Disaster Planning Conference 57101 2H1N1 Focus of California Hospital Association Disaster Planning Conference 57101 3MedEncentive and Medical Justice Announce Partnership 57097 1MedEncentive and Medical Justice Announce Partnership 57097 2MedEncentive and Medical Justice Announce Partnership 57097 3MedEncentive and Medical Justice Announce Partnership 57097 4aTyr Pharma to Present at BioPharm America 2009 14028 1aTyr Pharma to Present at BioPharm America 2009 14028 2
...HO, N.Y., June 5 bioMETRX Inc., (OTC,Bulletin Boa...sumer-based,finger-activated products, today annou...ric Solutions, LLC, to co-develop a new generation... technology to consumers at,an accelerated rate, g..."Biometric Solutions, LLC has had successful engin...
...research team has uncovered the likely target of n...ide a clearer picture of how this vitamin helps ma...d and thus lower the risk of heart disease. , Whi...anism of how it works has been mysterious, althoug...ease HDL production. Recent work had uncovered tha...
...This release is available in German . , Leipzig....mental Research have developed two new methods, in...f European Otters (Lutra lutra) and their effects ...eeded for the first time in gathering more accurat...nd region of the Oberlausitz Biosphere Reserve. Ge...
Other Biology News:bioMETRX, Inc. Partners with Biometric Solutions, LLC to Deliver Next Generation Finger Activated Technology 2bioMETRX, Inc. Partners with Biometric Solutions, LLC to Deliver Next Generation Finger Activated Technology 3Otters reveal their identity 2Otters reveal their identity 3Otters reveal their identity 4
... DuoSet ELISA Development kit contains the basic c... ELISAs to measure natural and recombinant mouse D...es and serum. Each kit contains sufficient materia...plates, provided that the following conditions are...
pCDF-1 Expression System plus Competent Cells from Novagen
Chicken Anti-Human Uridine Phosphorylase 1 Polyclonal Antibody, Unconjugated from Abcam
RayBio Mouse AngiogenesisAntibody Array I & 1.1 Service from Raybiotech, Inc.
Biology Products: